AGELESS
Sagging, lost volume and facial architecture. A protocol built around the bone-skin axis, dermal matrix and cellular energy.
SKINĒDIT Paris is a French nutricosmetics Maison founded in Paris in 2024. We develop targeted ingestible supplements for skin and hair around three concerns: facial firmness and volume, complexion clarity, and hair density. AGELESS, RADIANCE and REVIVAL are designed as 90-day protocols and manufactured in France.
Skin is what we see. Beneath it sit the dermal matrix, pigment pathways, follicular biology and facial support. We call this territory the 99%: a brand shorthand for what happens beneath the visible surface, not a measurement of topical penetration. Our ingestible protocols are designed to complement an external routine, not replace it.
For years I thought ageing was mainly a surface question. Retinol, acids, exceptional skincare: they could transform texture. But after forty-five, what I saw was no longer only a matter of texture. It was a matter of architecture.
“At a certain point I stopped looking only at the skin. I wanted to understand what beneath it contributes to shape, light and vitality.”
I brought together formulation experts and scientific partners to build ingestible protocols around precise biological pathways: the bone-skin axis and dermal matrix for AGELESS, pigmentation and clarity for RADIANCE, and the dermal papilla and hair cycle for REVIVAL. The idea was not to wage war on external skincare, but to open another level of the conversation.
Transparency is not an aesthetic. It is a way of formulating, sourcing and presenting evidence.
Every active is identified. The doses we publish are the ones our source material allows us to document clearly.
SKINĒDIT formulates ingestible supplements only. They complement external skincare through a different nutritional and systemic route.
The contents of our capsules are built around the formula's actives. The capsule shell is distinguished from its active contents.
Finished-product study, ingredient study, in-vitro data, mechanism or authorised claim: we aim to state what each piece of evidence actually demonstrates.
Formulated and manufactured in France under GMP and HACCP standards, with traceability from raw material to finished product.
A food supplement is neither surgery nor a medicine. We prefer ambitious formulation and rigorous interpretation to spectacular promises.
Not all evidence has the same status. That is precisely why we separate it.
Independent evaluation of the AGELESS protocol in 32 women aged 35–60 over 90 days. Detailed results and methodology are presented on the AGELESS protocol page.
The colorimetric and self-assessment results presented for RADIANCE document BELIGHT³™, the patented active, in its dedicated evaluation. They are not a clinical trial of the finished RADIANCE product.
AGELESS and RADIANCE received the Top Innovation 2025–2026 distinction. This recognition is separate from scientific studies and should be read as independent consumer validation.
Our rule: a statistic stays attached to the method that produced it. Ingredient data are not presented as finished-product results; customer feedback is not presented as a study; an award is not presented as a clinical measurement. Individual results vary. Food supplements do not replace a varied and balanced diet.
Shop the protocol, or enter its interactive scientific world.
Sagging, lost volume and facial architecture. A protocol built around the bone-skin axis, dermal matrix and cellular energy.
Dark spots, uneven tone and loss of clarity. A LumiTech 5™ architecture around pigment pathways, signalling and oxidative stress.
Shedding and loss of density. A protocol centred on the dermal papilla, growth signalling and the materials needed to rebuild the fibre.
Scientific dossiers, biological analysis and close reading of the studies behind our protocol actives and mechanisms.
Enter Intelligence ProfessionalsA dedicated space for professionals who want to understand SKINĒDIT formulation, documentation and protocol positioning.
Professional area Client CareProtocol guidance, formulation questions, press and partnerships. Replies written by our team.
Contact the team